Faron presents BEXMAB data at ASH Annual Meeting ...Middle East

PR Newswire - News
Faron presents BEXMAB data at ASH Annual Meeting
Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Presents Full Analysis of Positive Phase 2 Interim Data from BEXMAB Trial at the 66th American Society of Hematology (ASH) Annual Meeting Poster highlights Overall response rate of 80% (16 out of 20) in refractory or relapsed HMA...

Hence then, the article about faron presents bexmab data at ash annual meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Faron presents BEXMAB data at ASH Annual Meeting )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News